Europe
The acquisition of Pecher & Partners follows the firm’s earlier expansion into litigation to create a ‘one-stop shop’
The 2026 Life Sciences EMEA Awards is now open for entries. We are looking forward to reviewing and celebrating the industry's most impressive achievements and landmarks from the past year.
The tie-up between Perkins Coie and Ashurst may generate some striking numbers, but independent IP firms need not worry yet, according to practitioners
A dispute involving semiconductor technology and a partner's move from Hoffman Eitle to Hoyng Rokh Monegier were also among the top talking points
Sponsored
Sponsored
-
Sponsored by Gün and PartnersGüldeniz Doğan Alkan and Dilan Sıla Kayalıca of Gün + Partners highlight a Turkish Court of Cassation ruling that shows how a trademark owner’s actions – or inaction – can limit courts’ boundaries in assessing similarity -
Sponsored by Patrinos & KilimirisManolis Metaxakis of Patrinos & Kilimiris Law Offices considers the implications of the EUIPO ruling in favour of the Hellenic Republic concerning the validity of the ‘TurkAegean’ trademark
-
Sponsored by Bird & BirdLiz McAuliffe of Bird & Bird says Intel’s triumph against R2 Semiconductor in the High Court of England and Wales had a limited impact on parallel litigation in other jurisdictions before a high-stakes settlement
-
Sponsored by Maiwald Intellectual PropertyEva Ehlich and Anja Fux of Maiwald discuss a board of appeal decision on G 2/21’s interpretation, including a critical review of the interpretation in T 116/18 while denying a request for further review
-
Sponsored by Gün and PartnersSelin Sinem Erciyas and Zeynep Çağla Üstün explore whether Turkey, as a non-EU state party to the European Patent Convention, might still face the Unified Patent Court’s jurisdiction under EU regulations
-
Sponsored by Maiwald Intellectual PropertyChristian Meyer and Gisela Grabow of Maiwald explore proposed changes to new EU provisions aimed at facilitating faster market entry for generics and biosimilars, so as to allegedly bolster competition and enhance patient access
European Jurisdictions